Ultragenyx Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
18.02.26
/
50%
€17.40
Target price
18.02.27
€66.69
Performance (%)
10.34%
Price
11.03.26
€19.10
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 10.34%. This prediction currently runs until 18.02.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.301% |
| iShares Core DAX® | -2,53 % |
| iShares Nasdaq 100 | -0,03 % |
| iShares Nikkei 225® | -4,20 % |
| iShares S&P 500 | -0,80 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $128.00 to $79.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat